[Control mechanisms of tonus of smooth muscle of the prostate and their potential significance for pharmacotherapy of benign prostatic syndrome].
Uckert
S
S
Urologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover.
Kedia
G
G
Klocker
H
H
Sormes
M
M
Bartsch
G
G
Jonas
U
U
D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000502:physiology; D019332:Endothelin-1 / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D007537:Isometric Contraction / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009129:Muscle Tonus / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000503:physiopathology*; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D009924:Organ Culture Techniques; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011467:Prostate / Q000187:drug effects / Q000503:physiopathology*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology*
D019332:Endothelin-1; D020030:Nitric Oxide Donors; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors; D000242:Cyclic AMP; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006152:Cyclic GMP